Medipix is a family of read-out chips for particle imaging and detection developed by the Medipix Collaborations. The original concept of Medipix is that it works like a camera, detecting and counting each individual particle hitting the pixels when its electronic shutter is open. This enables high-resolution, high-contrast, noise hit free images – making it unique for imaging applications.
Hybrid pixel detector technology was initially developed to address the needs of particle tracking at the CERN LHC. The Medipix1 chip, which uses identical front-end circuitry to the Omega3 particle tracking chip, demonstrated the great potential for the technology outside of high-energy physics. To further develop this novel technology and take it into new scientific fields the Medipix2 Collaboration was started in 1999, the Medipix3 collaboration in 2005 and finally the Medipix4 collaboration in 2016.
Discover the different collaborations & technologies
MARS Bioimaging is seeking partners to better enable drug development and therapy monitoring for COVID-19 and other lung diseases
The current standard for definitive diagnosis of COVID-19 is the real-time reverse transcriptase-polymerase chain reaction (RT-PCR). While this is a highly sensitive and specific test for COVID-19, it does not measure the severity nor progress of the associated lung disease.Read more
As we prepare to send the first woman and next man to the Moon and on to Mars , NASA, with support from the University of Houston, has been working to develop advanced radiation detectors to better protect astronauts and vitalRead more